First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-09-19

AUTHORS

Riccardo Giampieri, Marco Puzzoni, Bruno Daniele, Daris Ferrari, Sara Lonardi, Alberto Zaniboni, Luigi Cavanna, Gerardo Rosati, Nicoletta Pella, Maria Giulia Zampino, Pietro Sozzi, Domenico Germano, Vittorina Zagonel, Carla Codecà, Michela Libertini, Roberto Labianca, Stefano Cascinu, , Mario Scartozzi

ABSTRACT

BACKGROUND: Previous findings suggested that bevacizumab might be able to improve response rate (RR) in colorectal cancer patients with high lactic dehydrogenase (LDH) basal levels. METHODS: We conducted a phase II trial to prospectively ascertain whether bevacizumab in combination with FOLFIRI could have an improved clinical activity in patients with high LDH serum levels. Primary end point of the study was RR; secondary end points were median overall survival and median progression-free survival (mPFS). RESULTS: A total of 81 patients were enrolled. No difference in terms of ORR (39% vs 31% for low vs high LDH level stratum, P=0.78) and mPFS (14.16 vs 10.29 months, HR: 1.07, 95% CI: 0.51-2.24, P=0.83) between the strata was observed, whereas overall survival (OS) was significantly longer for patients with low LDH (24.85 vs 15.14 months, HR: 4.08, 95% CI: 1.14-14.61, P=0.0004). In a not-pre-planned exploratory analysis using different cut-off ranges for LDH, we observed RR up to 70%, with no improvement in progression-free survival or OS. CONCLUSIONS: The CENTRAL trial failed to demonstrate that high LDH levels were related to a significantly improved RR in patients receiving first-line FOLFIRI and bevacizumab. The LDH serum levels should then no further be investigated as a predictive factor in this setting. More... »

PAGES

1099-1104

Journal

TITLE

British Journal of Cancer

ISSUE

8

VOLUME

117

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.2017.234

DOI

http://dx.doi.org/10.1038/bjc.2017.234

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1091834046

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28926529


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiogenesis Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bevacizumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Camptothecin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "L-Lactate Dehydrogenase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leucovorin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology Unit, University Hospital and Universit\u00e0 Politecnica delle Marche, Ancona, Italy", 
          "id": "http://www.grid.ac/institutes/grid.7010.6", 
          "name": [
            "Department of Medical Oncology Unit, University Hospital and Universit\u00e0 Politecnica delle Marche, Ancona, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giampieri", 
        "givenName": "Riccardo", 
        "id": "sg:person.01136342660.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136342660.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy", 
          "id": "http://www.grid.ac/institutes/grid.7763.5", 
          "name": [
            "Department of Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Puzzoni", 
        "givenName": "Marco", 
        "id": "sg:person.01266137065.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266137065.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology Unit, Ospedale G. Rummo, Benevento, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Medical Oncology Unit, Ospedale G. Rummo, Benevento, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Daniele", 
        "givenName": "Bruno", 
        "id": "sg:person.01231504560.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231504560.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology Unit, Azienda Ospedaliera San Paolo, Milano, Italy", 
          "id": "http://www.grid.ac/institutes/grid.415093.a", 
          "name": [
            "Department of Medical Oncology Unit, Azienda Ospedaliera San Paolo, Milano, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ferrari", 
        "givenName": "Daris", 
        "id": "sg:person.010637300302.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010637300302.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology Unit 1, Istituto Oncologico Veneto-IRCCS, Padova, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419546.b", 
          "name": [
            "Department of Medical Oncology Unit 1, Istituto Oncologico Veneto-IRCCS, Padova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lonardi", 
        "givenName": "Sara", 
        "id": "sg:person.01155122733.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155122733.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy", 
          "id": "http://www.grid.ac/institutes/grid.415090.9", 
          "name": [
            "Department of Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zaniboni", 
        "givenName": "Alberto", 
        "id": "sg:person.01007271605.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007271605.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology Unit, Ospedale di Piacenza, Piacenza, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Medical Oncology Unit, Ospedale di Piacenza, Piacenza, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cavanna", 
        "givenName": "Luigi", 
        "id": "sg:person.0771775231.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771775231.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology Unit, Ospedale San Carlo, Potenza, Italy", 
          "id": "http://www.grid.ac/institutes/grid.416325.7", 
          "name": [
            "Department of Medical Oncology Unit, Ospedale San Carlo, Potenza, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rosati", 
        "givenName": "Gerardo", 
        "id": "sg:person.01362033743.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362033743.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology Unit, Azienda Ospedaliero Universitaria Santa Maria della Misericordia, Udine, Italy", 
          "id": "http://www.grid.ac/institutes/grid.411492.b", 
          "name": [
            "Department of Medical Oncology Unit, Azienda Ospedaliero Universitaria Santa Maria della Misericordia, Udine, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pella", 
        "givenName": "Nicoletta", 
        "id": "sg:person.0776162450.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776162450.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastrointestinal Medical Oncology Unit and Neuroendocrine Tumors, Istituto Europeo di Oncologia\u2014IRCCS, Milano, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Gastrointestinal Medical Oncology Unit and Neuroendocrine Tumors, Istituto Europeo di Oncologia\u2014IRCCS, Milano, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zampino", 
        "givenName": "Maria Giulia", 
        "id": "sg:person.01007732510.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007732510.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology Unit, Nuovo Ospedale degli Infermi, Biella, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417165.0", 
          "name": [
            "Department of Medical Oncology Unit, Nuovo Ospedale degli Infermi, Biella, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sozzi", 
        "givenName": "Pietro", 
        "id": "sg:person.013300665323.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013300665323.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology Unit, Ospedale G. Rummo, Benevento, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Medical Oncology Unit, Ospedale G. Rummo, Benevento, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Germano", 
        "givenName": "Domenico", 
        "id": "sg:person.01174372161.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174372161.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology Unit 1, Istituto Oncologico Veneto-IRCCS, Padova, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419546.b", 
          "name": [
            "Department of Medical Oncology Unit 1, Istituto Oncologico Veneto-IRCCS, Padova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zagonel", 
        "givenName": "Vittorina", 
        "id": "sg:person.0622706463.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622706463.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology Unit, Azienda Ospedaliera San Paolo, Milano, Italy", 
          "id": "http://www.grid.ac/institutes/grid.415093.a", 
          "name": [
            "Department of Medical Oncology Unit, Azienda Ospedaliera San Paolo, Milano, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Codec\u00e0", 
        "givenName": "Carla", 
        "id": "sg:person.01325237745.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01325237745.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy", 
          "id": "http://www.grid.ac/institutes/grid.415090.9", 
          "name": [
            "Department of Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Libertini", 
        "givenName": "Michela", 
        "id": "sg:person.0655377426.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655377426.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy", 
          "id": "http://www.grid.ac/institutes/grid.460094.f", 
          "name": [
            "Department of Medical Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Labianca", 
        "givenName": "Roberto", 
        "id": "sg:person.01070501201.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070501201.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology/Hematology, Universit\u00e0 di Modena e Reggio Emilia, Modena, Italy", 
          "id": "http://www.grid.ac/institutes/grid.7548.e", 
          "name": [
            "Department of Modena Cancer Center, Universit\u00e0 di Modena e Reggio Emilia, Modena, Italy", 
            "Department of Oncology/Hematology, Universit\u00e0 di Modena e Reggio Emilia, Modena, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cascinu", 
        "givenName": "Stefano", 
        "id": "sg:person.01157163143.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157163143.28"
        ], 
        "type": "Person"
      }, 
      {}, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy", 
          "id": "http://www.grid.ac/institutes/grid.7763.5", 
          "name": [
            "Department of Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scartozzi", 
        "givenName": "Mario", 
        "id": "sg:person.01222636463.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222636463.05"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bjc.2016.413", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053083710", 
          "https://doi.org/10.1038/bjc.2016.413"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12885-016-2276-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018872542", 
          "https://doi.org/10.1186/s12885-016-2276-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10585-005-2343-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016076125", 
          "https://doi.org/10.1007/s10585-005-2343-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2012.17", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042978197", 
          "https://doi.org/10.1038/bjc.2012.17"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-09-19", 
    "datePublishedReg": "2017-09-19", 
    "description": "BACKGROUND: Previous findings suggested that bevacizumab might be able to improve response rate (RR) in colorectal cancer patients with high lactic dehydrogenase (LDH) basal levels.\nMETHODS: We conducted a phase II trial to prospectively ascertain whether bevacizumab in combination with FOLFIRI could have an improved clinical activity in patients with high LDH serum levels. Primary end point of the study was RR; secondary end points were median overall survival and median progression-free survival (mPFS).\nRESULTS: A total of 81 patients were enrolled. No difference in terms of ORR (39% vs 31% for low vs high LDH level stratum, P=0.78) and mPFS (14.16 vs 10.29 months, HR: 1.07, 95% CI: 0.51-2.24, P=0.83) between the strata was observed, whereas overall survival (OS) was significantly longer for patients with low LDH (24.85 vs 15.14 months, HR: 4.08, 95% CI: 1.14-14.61, P=0.0004). In a not-pre-planned exploratory analysis using different cut-off ranges for LDH, we observed RR up to 70%, with no improvement in progression-free survival or OS.\nCONCLUSIONS: The CENTRAL trial failed to demonstrate that high LDH levels were related to a significantly improved RR in patients receiving first-line FOLFIRI and bevacizumab. The LDH serum levels should then no further be investigated as a predictive factor in this setting.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/bjc.2017.234", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "117"
      }
    ], 
    "keywords": [
      "median progression-free survival", 
      "first-line FOLFIRI", 
      "progression-free survival", 
      "LDH serum levels", 
      "overall survival", 
      "response rate", 
      "serum levels", 
      "high LDH serum levels", 
      "pre-planned exploratory analysis", 
      "end point", 
      "Central Trials", 
      "improved clinical activity", 
      "primary end point", 
      "Secondary end points", 
      "median overall survival", 
      "phase II trial", 
      "high LDH level", 
      "advanced colorectal cancer", 
      "colorectal cancer patients", 
      "II trial", 
      "terms of ORR", 
      "serum LDH", 
      "LDH levels", 
      "predictive factors", 
      "colorectal cancer", 
      "cancer patients", 
      "low LDH", 
      "clinical activity", 
      "bevacizumab", 
      "patients", 
      "FOLFIRI", 
      "basal levels", 
      "trials", 
      "survival", 
      "exploratory analysis", 
      "different cut", 
      "previous findings", 
      "LDH", 
      "levels", 
      "cancer", 
      "total", 
      "findings", 
      "setting", 
      "factors", 
      "differences", 
      "activity", 
      "study", 
      "rate", 
      "improvement", 
      "combination", 
      "final results", 
      "point", 
      "analysis", 
      "results", 
      "cut", 
      "ORR", 
      "strata", 
      "range", 
      "terms", 
      "high lactic dehydrogenase (LDH) basal levels", 
      "lactic dehydrogenase (LDH) basal levels", 
      "dehydrogenase (LDH) basal levels", 
      "GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial"
    ], 
    "name": "First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial", 
    "pagination": "1099-1104", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1091834046"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.2017.234"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28926529"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.2017.234", 
      "https://app.dimensions.ai/details/publication/pub.1091834046"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_733.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/bjc.2017.234"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.2017.234'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.2017.234'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.2017.234'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.2017.234'


 

This table displays all metadata directly associated to this object as RDF triples.

369 TRIPLES      22 PREDICATES      111 URIs      99 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.2017.234 schema:about N0073a30f0f3b47d296ef80316956168e
2 N0719bdbfab854dba9b99d82b4c371e38
3 N22ca6157c6bf403698292b466e92c5ab
4 N350bfe91898c4d17937de75e1b99647f
5 N3d1dab496ebd47f99334069786c236a8
6 N3fe65485b6c94d578ed5de9559856632
7 N52fe56969a064f89ac7168ec82c1ec91
8 N90280b0cf6324967af04dccb4c69921c
9 N94f224f0753f4c18a6c6f18d568affe8
10 N96b798337a44490a934b3c945115b948
11 N9909186e4bdd4d708059c2f935f2b422
12 Na64f4a3852324e9ea4ee27b6d6387105
13 Na9bcc4d51814490fab76f2289efe8aa7
14 Nbbf0925709264d12bde27f5e744d6bc1
15 Nc3220d992aed42b2a96996047a8456b7
16 Neacb2db5e0dc4265b52bc445ee68a3cd
17 Nf77d185c2c9543bda6d15204e16e6c0e
18 Nf898a6f2d5294354b122bcffcfd0bc52
19 anzsrc-for:11
20 anzsrc-for:1112
21 schema:author N700457916d354950a0e415f47417e2a0
22 schema:citation sg:pub.10.1007/s10585-005-2343-7
23 sg:pub.10.1038/bjc.2012.17
24 sg:pub.10.1038/bjc.2016.413
25 sg:pub.10.1186/s12885-016-2276-3
26 schema:datePublished 2017-09-19
27 schema:datePublishedReg 2017-09-19
28 schema:description BACKGROUND: Previous findings suggested that bevacizumab might be able to improve response rate (RR) in colorectal cancer patients with high lactic dehydrogenase (LDH) basal levels. METHODS: We conducted a phase II trial to prospectively ascertain whether bevacizumab in combination with FOLFIRI could have an improved clinical activity in patients with high LDH serum levels. Primary end point of the study was RR; secondary end points were median overall survival and median progression-free survival (mPFS). RESULTS: A total of 81 patients were enrolled. No difference in terms of ORR (39% vs 31% for low vs high LDH level stratum, P=0.78) and mPFS (14.16 vs 10.29 months, HR: 1.07, 95% CI: 0.51-2.24, P=0.83) between the strata was observed, whereas overall survival (OS) was significantly longer for patients with low LDH (24.85 vs 15.14 months, HR: 4.08, 95% CI: 1.14-14.61, P=0.0004). In a not-pre-planned exploratory analysis using different cut-off ranges for LDH, we observed RR up to 70%, with no improvement in progression-free survival or OS. CONCLUSIONS: The CENTRAL trial failed to demonstrate that high LDH levels were related to a significantly improved RR in patients receiving first-line FOLFIRI and bevacizumab. The LDH serum levels should then no further be investigated as a predictive factor in this setting.
29 schema:genre article
30 schema:inLanguage en
31 schema:isAccessibleForFree true
32 schema:isPartOf Ndcf8b51cfbae4ff5ab7f847384da92b5
33 Nec73ff5366d04ef4b9af50ef3d44871c
34 sg:journal.1017082
35 schema:keywords Central Trials
36 FOLFIRI
37 GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial
38 II trial
39 LDH
40 LDH levels
41 LDH serum levels
42 ORR
43 Secondary end points
44 activity
45 advanced colorectal cancer
46 analysis
47 basal levels
48 bevacizumab
49 cancer
50 cancer patients
51 clinical activity
52 colorectal cancer
53 colorectal cancer patients
54 combination
55 cut
56 dehydrogenase (LDH) basal levels
57 differences
58 different cut
59 end point
60 exploratory analysis
61 factors
62 final results
63 findings
64 first-line FOLFIRI
65 high LDH level
66 high LDH serum levels
67 high lactic dehydrogenase (LDH) basal levels
68 improved clinical activity
69 improvement
70 lactic dehydrogenase (LDH) basal levels
71 levels
72 low LDH
73 median overall survival
74 median progression-free survival
75 overall survival
76 patients
77 phase II trial
78 point
79 pre-planned exploratory analysis
80 predictive factors
81 previous findings
82 primary end point
83 progression-free survival
84 range
85 rate
86 response rate
87 results
88 serum LDH
89 serum levels
90 setting
91 strata
92 study
93 survival
94 terms
95 terms of ORR
96 total
97 trials
98 schema:name First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial
99 schema:pagination 1099-1104
100 schema:productId Nb3b881fe26bd4859bc6a762b693412b4
101 Ncad88fbe45a64b818cfa8771d1296d5c
102 Nfeaaac85fd2c45d28c6f544627176414
103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091834046
104 https://doi.org/10.1038/bjc.2017.234
105 schema:sdDatePublished 2021-11-01T18:31
106 schema:sdLicense https://scigraph.springernature.com/explorer/license/
107 schema:sdPublisher Nc1c9cba04585423dbf83986f08a07f03
108 schema:url https://doi.org/10.1038/bjc.2017.234
109 sgo:license sg:explorer/license/
110 sgo:sdDataset articles
111 rdf:type schema:ScholarlyArticle
112 N0073a30f0f3b47d296ef80316956168e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Fluorouracil
114 rdf:type schema:DefinedTerm
115 N0719bdbfab854dba9b99d82b4c371e38 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Adult
117 rdf:type schema:DefinedTerm
118 N172a0d8ecf354948a584a9ef04f8adb8 rdf:first sg:person.01231504560.97
119 rdf:rest N5dc747012bb94a1ab395bd307ef78fa1
120 N1a1ccf38a1c942d5bf6b7ac195750a2d rdf:first sg:person.01157163143.28
121 rdf:rest N1fb0b5b396fd43beb1f770c47bc7f039
122 N1fb0b5b396fd43beb1f770c47bc7f039 rdf:first Na3d1e4e093664ae8943c3047eb033670
123 rdf:rest Nb20741a6a9944710a6c11d8be6e9707e
124 N22ca6157c6bf403698292b466e92c5ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Bevacizumab
126 rdf:type schema:DefinedTerm
127 N350bfe91898c4d17937de75e1b99647f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Disease-Free Survival
129 rdf:type schema:DefinedTerm
130 N37b0c67599d24bb48e57d1584846d750 rdf:first sg:person.01155122733.59
131 rdf:rest Nb5812523193f495788fde20be28e3550
132 N3c1a477b2b0c4c97a442a748f5e3fa96 rdf:first sg:person.01266137065.17
133 rdf:rest N172a0d8ecf354948a584a9ef04f8adb8
134 N3d1dab496ebd47f99334069786c236a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Humans
136 rdf:type schema:DefinedTerm
137 N3fe65485b6c94d578ed5de9559856632 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Female
139 rdf:type schema:DefinedTerm
140 N4f93415d762a4672a9ff20cb6dfca30d rdf:first sg:person.0655377426.63
141 rdf:rest N5c0af4b0defb426c8086d4e89ac42383
142 N52fe56969a064f89ac7168ec82c1ec91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Aged
144 rdf:type schema:DefinedTerm
145 N5c0af4b0defb426c8086d4e89ac42383 rdf:first sg:person.01070501201.50
146 rdf:rest N1a1ccf38a1c942d5bf6b7ac195750a2d
147 N5dc747012bb94a1ab395bd307ef78fa1 rdf:first sg:person.010637300302.03
148 rdf:rest N37b0c67599d24bb48e57d1584846d750
149 N700457916d354950a0e415f47417e2a0 rdf:first sg:person.01136342660.94
150 rdf:rest N3c1a477b2b0c4c97a442a748f5e3fa96
151 N72d91f9dd10941429a4c5421b99c0b7e rdf:first sg:person.0776162450.70
152 rdf:rest Nf6f365049ab1493cb589345f93ab6f08
153 N7cb94ea2c7d44fcbaf6b2fadf11fde92 rdf:first sg:person.01174372161.08
154 rdf:rest Naf736cbf300443aab480fb42cf5b9e27
155 N8fcb2f402ccc44aea53418cab9d3f8d4 rdf:first sg:person.01325237745.64
156 rdf:rest N4f93415d762a4672a9ff20cb6dfca30d
157 N90280b0cf6324967af04dccb4c69921c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Aged, 80 and over
159 rdf:type schema:DefinedTerm
160 N94f224f0753f4c18a6c6f18d568affe8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Treatment Outcome
162 rdf:type schema:DefinedTerm
163 N96b798337a44490a934b3c945115b948 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Prospective Studies
165 rdf:type schema:DefinedTerm
166 N9909186e4bdd4d708059c2f935f2b422 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name L-Lactate Dehydrogenase
168 rdf:type schema:DefinedTerm
169 N9d1b1d415dc64bc0b7e5aec0f2ecc699 rdf:first sg:person.0771775231.11
170 rdf:rest Nb3976408385f4210b427800c044d95fb
171 Na64f4a3852324e9ea4ee27b6d6387105 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Male
173 rdf:type schema:DefinedTerm
174 Na9bcc4d51814490fab76f2289efe8aa7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Antineoplastic Combined Chemotherapy Protocols
176 rdf:type schema:DefinedTerm
177 Naf736cbf300443aab480fb42cf5b9e27 rdf:first sg:person.0622706463.81
178 rdf:rest N8fcb2f402ccc44aea53418cab9d3f8d4
179 Nb20741a6a9944710a6c11d8be6e9707e rdf:first sg:person.01222636463.05
180 rdf:rest rdf:nil
181 Nb3976408385f4210b427800c044d95fb rdf:first sg:person.01362033743.92
182 rdf:rest N72d91f9dd10941429a4c5421b99c0b7e
183 Nb3b881fe26bd4859bc6a762b693412b4 schema:name doi
184 schema:value 10.1038/bjc.2017.234
185 rdf:type schema:PropertyValue
186 Nb5812523193f495788fde20be28e3550 rdf:first sg:person.01007271605.65
187 rdf:rest N9d1b1d415dc64bc0b7e5aec0f2ecc699
188 Nbbf0925709264d12bde27f5e744d6bc1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Angiogenesis Inhibitors
190 rdf:type schema:DefinedTerm
191 Nc1c9cba04585423dbf83986f08a07f03 schema:name Springer Nature - SN SciGraph project
192 rdf:type schema:Organization
193 Nc3220d992aed42b2a96996047a8456b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Colorectal Neoplasms
195 rdf:type schema:DefinedTerm
196 Ncad88fbe45a64b818cfa8771d1296d5c schema:name pubmed_id
197 schema:value 28926529
198 rdf:type schema:PropertyValue
199 Nd9f49b0f71624e709742b178dc0742be rdf:first sg:person.013300665323.25
200 rdf:rest N7cb94ea2c7d44fcbaf6b2fadf11fde92
201 Ndcf8b51cfbae4ff5ab7f847384da92b5 schema:volumeNumber 117
202 rdf:type schema:PublicationVolume
203 Neacb2db5e0dc4265b52bc445ee68a3cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Middle Aged
205 rdf:type schema:DefinedTerm
206 Nec73ff5366d04ef4b9af50ef3d44871c schema:issueNumber 8
207 rdf:type schema:PublicationIssue
208 Nf6f365049ab1493cb589345f93ab6f08 rdf:first sg:person.01007732510.81
209 rdf:rest Nd9f49b0f71624e709742b178dc0742be
210 Nf77d185c2c9543bda6d15204e16e6c0e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Camptothecin
212 rdf:type schema:DefinedTerm
213 Nf898a6f2d5294354b122bcffcfd0bc52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Leucovorin
215 rdf:type schema:DefinedTerm
216 Nfeaaac85fd2c45d28c6f544627176414 schema:name dimensions_id
217 schema:value pub.1091834046
218 rdf:type schema:PropertyValue
219 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
220 schema:name Medical and Health Sciences
221 rdf:type schema:DefinedTerm
222 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
223 schema:name Oncology and Carcinogenesis
224 rdf:type schema:DefinedTerm
225 sg:journal.1017082 schema:issn 0007-0920
226 1532-1827
227 schema:name British Journal of Cancer
228 schema:publisher Springer Nature
229 rdf:type schema:Periodical
230 sg:person.01007271605.65 schema:affiliation grid-institutes:grid.415090.9
231 schema:familyName Zaniboni
232 schema:givenName Alberto
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007271605.65
234 rdf:type schema:Person
235 sg:person.01007732510.81 schema:affiliation grid-institutes:None
236 schema:familyName Zampino
237 schema:givenName Maria Giulia
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007732510.81
239 rdf:type schema:Person
240 sg:person.010637300302.03 schema:affiliation grid-institutes:grid.415093.a
241 schema:familyName Ferrari
242 schema:givenName Daris
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010637300302.03
244 rdf:type schema:Person
245 sg:person.01070501201.50 schema:affiliation grid-institutes:grid.460094.f
246 schema:familyName Labianca
247 schema:givenName Roberto
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070501201.50
249 rdf:type schema:Person
250 sg:person.01136342660.94 schema:affiliation grid-institutes:grid.7010.6
251 schema:familyName Giampieri
252 schema:givenName Riccardo
253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136342660.94
254 rdf:type schema:Person
255 sg:person.01155122733.59 schema:affiliation grid-institutes:grid.419546.b
256 schema:familyName Lonardi
257 schema:givenName Sara
258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155122733.59
259 rdf:type schema:Person
260 sg:person.01157163143.28 schema:affiliation grid-institutes:grid.7548.e
261 schema:familyName Cascinu
262 schema:givenName Stefano
263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157163143.28
264 rdf:type schema:Person
265 sg:person.01174372161.08 schema:affiliation grid-institutes:None
266 schema:familyName Germano
267 schema:givenName Domenico
268 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174372161.08
269 rdf:type schema:Person
270 sg:person.01222636463.05 schema:affiliation grid-institutes:grid.7763.5
271 schema:familyName Scartozzi
272 schema:givenName Mario
273 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222636463.05
274 rdf:type schema:Person
275 sg:person.01231504560.97 schema:affiliation grid-institutes:None
276 schema:familyName Daniele
277 schema:givenName Bruno
278 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231504560.97
279 rdf:type schema:Person
280 sg:person.01266137065.17 schema:affiliation grid-institutes:grid.7763.5
281 schema:familyName Puzzoni
282 schema:givenName Marco
283 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266137065.17
284 rdf:type schema:Person
285 sg:person.01325237745.64 schema:affiliation grid-institutes:grid.415093.a
286 schema:familyName Codecà
287 schema:givenName Carla
288 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01325237745.64
289 rdf:type schema:Person
290 sg:person.013300665323.25 schema:affiliation grid-institutes:grid.417165.0
291 schema:familyName Sozzi
292 schema:givenName Pietro
293 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013300665323.25
294 rdf:type schema:Person
295 sg:person.01362033743.92 schema:affiliation grid-institutes:grid.416325.7
296 schema:familyName Rosati
297 schema:givenName Gerardo
298 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362033743.92
299 rdf:type schema:Person
300 sg:person.0622706463.81 schema:affiliation grid-institutes:grid.419546.b
301 schema:familyName Zagonel
302 schema:givenName Vittorina
303 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622706463.81
304 rdf:type schema:Person
305 sg:person.0655377426.63 schema:affiliation grid-institutes:grid.415090.9
306 schema:familyName Libertini
307 schema:givenName Michela
308 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655377426.63
309 rdf:type schema:Person
310 sg:person.0771775231.11 schema:affiliation grid-institutes:None
311 schema:familyName Cavanna
312 schema:givenName Luigi
313 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771775231.11
314 rdf:type schema:Person
315 sg:person.0776162450.70 schema:affiliation grid-institutes:grid.411492.b
316 schema:familyName Pella
317 schema:givenName Nicoletta
318 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776162450.70
319 rdf:type schema:Person
320 sg:pub.10.1007/s10585-005-2343-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016076125
321 https://doi.org/10.1007/s10585-005-2343-7
322 rdf:type schema:CreativeWork
323 sg:pub.10.1038/bjc.2012.17 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042978197
324 https://doi.org/10.1038/bjc.2012.17
325 rdf:type schema:CreativeWork
326 sg:pub.10.1038/bjc.2016.413 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053083710
327 https://doi.org/10.1038/bjc.2016.413
328 rdf:type schema:CreativeWork
329 sg:pub.10.1186/s12885-016-2276-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018872542
330 https://doi.org/10.1186/s12885-016-2276-3
331 rdf:type schema:CreativeWork
332 grid-institutes:None schema:alternateName Department of Gastrointestinal Medical Oncology Unit and Neuroendocrine Tumors, Istituto Europeo di Oncologia—IRCCS, Milano, Italy
333 Department of Medical Oncology Unit, Ospedale G. Rummo, Benevento, Italy
334 Department of Medical Oncology Unit, Ospedale di Piacenza, Piacenza, Italy
335 schema:name Department of Gastrointestinal Medical Oncology Unit and Neuroendocrine Tumors, Istituto Europeo di Oncologia—IRCCS, Milano, Italy
336 Department of Medical Oncology Unit, Ospedale G. Rummo, Benevento, Italy
337 Department of Medical Oncology Unit, Ospedale di Piacenza, Piacenza, Italy
338 rdf:type schema:Organization
339 grid-institutes:grid.411492.b schema:alternateName Department of Medical Oncology Unit, Azienda Ospedaliero Universitaria Santa Maria della Misericordia, Udine, Italy
340 schema:name Department of Medical Oncology Unit, Azienda Ospedaliero Universitaria Santa Maria della Misericordia, Udine, Italy
341 rdf:type schema:Organization
342 grid-institutes:grid.415090.9 schema:alternateName Department of Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy
343 schema:name Department of Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy
344 rdf:type schema:Organization
345 grid-institutes:grid.415093.a schema:alternateName Department of Medical Oncology Unit, Azienda Ospedaliera San Paolo, Milano, Italy
346 schema:name Department of Medical Oncology Unit, Azienda Ospedaliera San Paolo, Milano, Italy
347 rdf:type schema:Organization
348 grid-institutes:grid.416325.7 schema:alternateName Department of Medical Oncology Unit, Ospedale San Carlo, Potenza, Italy
349 schema:name Department of Medical Oncology Unit, Ospedale San Carlo, Potenza, Italy
350 rdf:type schema:Organization
351 grid-institutes:grid.417165.0 schema:alternateName Department of Medical Oncology Unit, Nuovo Ospedale degli Infermi, Biella, Italy
352 schema:name Department of Medical Oncology Unit, Nuovo Ospedale degli Infermi, Biella, Italy
353 rdf:type schema:Organization
354 grid-institutes:grid.419546.b schema:alternateName Department of Medical Oncology Unit 1, Istituto Oncologico Veneto-IRCCS, Padova, Italy
355 schema:name Department of Medical Oncology Unit 1, Istituto Oncologico Veneto-IRCCS, Padova, Italy
356 rdf:type schema:Organization
357 grid-institutes:grid.460094.f schema:alternateName Department of Medical Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
358 schema:name Department of Medical Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
359 rdf:type schema:Organization
360 grid-institutes:grid.7010.6 schema:alternateName Department of Medical Oncology Unit, University Hospital and Università Politecnica delle Marche, Ancona, Italy
361 schema:name Department of Medical Oncology Unit, University Hospital and Università Politecnica delle Marche, Ancona, Italy
362 rdf:type schema:Organization
363 grid-institutes:grid.7548.e schema:alternateName Department of Oncology/Hematology, Università di Modena e Reggio Emilia, Modena, Italy
364 schema:name Department of Modena Cancer Center, Università di Modena e Reggio Emilia, Modena, Italy
365 Department of Oncology/Hematology, Università di Modena e Reggio Emilia, Modena, Italy
366 rdf:type schema:Organization
367 grid-institutes:grid.7763.5 schema:alternateName Department of Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy
368 schema:name Department of Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy
369 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...